Cvs Stock Quote and Financial Performance Overview

CVS stock has consistently shown strong financial performance over the years, with a market capitalization of over $200 billion.

CVS Health's revenue has been steadily increasing, reaching a high of $256 billion in 2020, largely due to its diversified business model that includes pharmacy services, health insurance, and healthcare services.

The company's net income has also been impressive, reaching $7.5 billion in 2020, up from $4.8 billion in 2015. This growth can be attributed to CVS Health's successful acquisition of Aetna in 2018, which expanded its presence in the health insurance market.

CVS Health's stock price has also shown significant growth, with a high of over $100 per share in 2020, up from around $50 per share in 2015.

Take a look at this: Stock Market Crash

The CVS Health stock price has been on a rollercoaster ride, with a notable rebound to $48 on Monday, up 10% from its lowest in December. This is after the strong Walgreens Boots Alliance earnings pushed the stock up almost 5%.

Looking at the 1-Month performance, we see that the stock price started at 43.65, a 30.58% increase from its low on 12/30/24. However, it then dropped to 57.33, a 0.58% decrease from its high on 01/28/25.

In the 3-Month and 52-Week periods, the stock price started at 43.56, a 30.85% increase from its low on 12/23/24. It then peaked at 63.33, a 10% decrease from its high on 11/06/24.

The 52-Week period also saw the stock price drop to 80.75, a 29.41% decrease from its high on 03/28/24.

Here's a breakdown of the stock performance over the past few months:

CVS Health's financial performance is also worth noting, with revenue increasing by 10.88% in 2023 to $356.62 billion, and earnings rising by 93.55% to $8.34 billion.

CVS stock has seen significant growth in its financial performance. In 2023, the company's revenue reached $356.62 billion, a 10.88% increase from the previous year.

The company's earnings were $8.34 billion, a substantial 93.55% increase from the previous year.

Here are some key financial metrics for CVS stock:

The company's price-to-earnings ratio (ttm) is 8.59, and its earnings per share (ttm) are $6.35. The most recent earnings were $1.09, and the next earnings date is February 12, 2025.

The analysts are optimistic about CVS stock, with an average rating of "Buy" from 16 experts.

The 12-month forecast is quite promising, with a predicted stock price of $68.63, representing a 19.96% increase from the latest price.

This growth potential is certainly a draw for investors, offering a chance to see a significant return on investment.

The forecasted price of $68.63 is a clear indication of the analysts' confidence in CVS stock's future performance.

According to the Barchart Technical Opinion, the current rating is a 24% Sell, indicating a bearish outlook on the stock.

The short-term outlook is Weakening, suggesting that the current direction may not be sustainable.

This technical analysis suggests that investors may want to consider selling their shares or at least be cautious with their investments.

The current technical opinion rating is a clear warning sign for investors to reevaluate their positions.

It's always a good idea to consider multiple sources and opinions before making any investment decisions.

A different take: B a E Systems Share Price

CVS Health has been named as a Top 25 dividend stock, according to the most recent Dividend Channel "DividendRank" report. The report noted that among the coverage universe, CVS shares displayed both a 5.81% yield and a discount to book value.

CVS Health's 5.81% yield is an attractive feature for investors seeking dividend income. This yield is higher than the average dividend yield of many other stocks in the market.

The company's well-covered payout ratio of 55.9% also indicates a strong financial position to sustain its dividend payments. This is a key factor for investors who want to ensure their dividend income is secure.

Readers also liked: Bt Group Lse

CVS Health's stock price has declined by 43% in recent times, but its dividend yield remains attractive. This means investors can buy the stock at a relatively lower price and still earn a decent dividend income.

Here's a summary of CVS Health's dividend and share buyback metrics:

CVS Health's strong dividend growth rate of 6.6% over the past three years is another positive factor for investors. This indicates that the company's dividend income is likely to increase in the future, making it an attractive investment option.

For more insights, see: S B I Card Share Price

CVS Health is a healthcare company that operates a chain of pharmacies and health clinics across the US.

CVS Health is headquartered in Woonsocket, Rhode Island, where the company was founded in 1963.

The company has a market value of over $200 billion, making it one of the largest healthcare companies in the world.

We're a company that's been around for a while, founded in 2010 by a group of passionate entrepreneurs who wanted to make a real difference in the world. Our mission has remained the same ever since: to provide innovative solutions to everyday problems.

Our headquarters is located in a vibrant city with a strong sense of community, where we have a diverse team of over 200 employees from all walks of life. We're proud to say that our company culture is built on values like collaboration, creativity, and a commitment to excellence.

We've grown significantly over the years, with a revenue of $50 million in 2020 and a presence in over 10 countries worldwide. Our products and services have been used by millions of people, and we're constantly looking for ways to improve and expand our offerings.

At the heart of our company is a team of dedicated professionals who share a common goal: to make a positive impact on people's lives. We believe that our work has the power to change the world, and we're committed to doing our part.

CVS Pharmacy has achieved a significant milestone with CVS CostVantage.

This innovative approach uses a transparent formula built on the drug acquisition cost.

All commercial prescriptions dispensed at CVS Pharmacy will be reimbursed through CVS CostVantage starting this year.

This means patients will have a clear understanding of the costs associated with their prescriptions.